Italian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
antidiabetic/infarto
Il collegamento viene salvato negli appunti
7 risultati
Combinations
Solo gli utenti registrati possono tradurre articoli
Entra registrati
COMBINATIONS
The present invention relates to a combination, especially a pharmaceutical composition, comprising (a) a PDE 5 inhibitor or a pharmaceutically acceptable salt thereof and (b) at least one active ingredient selected from the group consisting of (i) an anti-diabetic agent; (ii) HMG-Co-A
Use of conantokins
Solo gli utenti registrati possono tradurre articoli
Entra registrati
BACKGROUND OF THE INVENTION
The invention relates to the use of relatively short peptides, about 10-30 residues in length, which are naturally available in minute amounts in the venom of the cone snails or analogous to the naturally available peptides, and which include preferably one to two or more
Use of conantokins
Solo gli utenti registrati possono tradurre articoli
Entra registrati
BACKGROUND OF THE INVENTION
The invention relates to the use of relatively short peptides, about 10-30 residues in length, which are naturally available in minute amounts in the venom of the cone snails or analogous to the naturaly available peptides, and which include preferably one to two or more
Therapeutic agent for ischemia which inhibits apoptosis under ischemic condition
Solo gli utenti registrati possono tradurre articoli
Entra registrati
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to a therapeutic agent for ischemia, more specifically, to a therapeutic agent for ischemia which inhibits apoptosis under ischemic condition.
2. Description of the Prior Art
As the death rate from cardiovascular
Organic compounds
Solo gli utenti registrati possono tradurre articoli
Entra registrati
BACKGROUND
Compounds that bind to Peroxisome Proliferator-Activated Receptors (PPARs) are useful for the treatment of dyslipidemia, hyperlipidemia, atherosclerosis, hypertriglyceridemia, heart failure, myocardial infarction, vascular diseases, cardiovascular diseases, hypertension, obesity,
Heterocyclic compounds and methods of use
Solo gli utenti registrati possono tradurre articoli
Entra registrati
The present invention relates to heterocyclic compounds, pharmaceutical compositions containing them and to methods of treating conditions associated with the Retinoid X Receptor (RXR) and the Peroxisome Proliferator-Activated Receptor (PPAR) families with the three subtypes PPAR.alpha., PPAR.delta.
Use of heterocyclic amino-alcohol compounds for treatment of CNS diseases
Solo gli utenti registrati possono tradurre articoli
Entra registrati
FIELD OF INVENTION
This invention is in the field of clinical neurology and relates specifically to a class of compounds, compositions and methods for CNS-disease treatment, such as for controlling or treating chronic or acute neuronoxic injury or brain damage resulting from ischemic conditions, and
Il database di erbe medicinali più completo supportato dalla scienza
- Funziona in 55 lingue
- Cure a base di erbe sostenute dalla scienza
- Riconoscimento delle erbe per immagine
- Mappa GPS interattiva - tagga le erbe sul luogo (disponibile a breve)
- Leggi le pubblicazioni scientifiche relative alla tua ricerca
- Cerca le erbe medicinali in base ai loro effetti
- Organizza i tuoi interessi e tieniti aggiornato sulle notizie di ricerca, sperimentazioni cliniche e brevetti
Digita un sintomo o una malattia e leggi le erbe che potrebbero aiutare, digita un'erba e osserva le malattie ei sintomi contro cui è usata.
* Tutte le informazioni si basano su ricerche scientifiche pubblicate
